Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.49
+0.92 (20.13%)
At close: Jun 6, 2025, 4:00 PM
5.57
+0.08 (1.46%)
After-hours: Jun 6, 2025, 7:59 PM EDT

Recursion Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
59.7958.8444.5839.8410.183.96
Upgrade
Revenue Growth (YoY)
29.32%32.00%11.88%291.46%156.89%70.85%
Upgrade
Cost of Revenue
432.4359.66283.81203.97135.2763.32
Upgrade
Gross Profit
-372.61-300.82-239.24-164.13-125.09-59.36
Upgrade
Selling, General & Admin
201.43178.18110.8281.657.6825.26
Upgrade
Operating Expenses
201.43178.18110.8281.657.6825.26
Upgrade
Operating Income
-574.03-479-350.06-245.73-182.78-84.62
Upgrade
Interest Expense
-2.06-1.57-0.1-0.06-2.95-1.36
Upgrade
Interest & Investment Income
17.2715.7619.126.250.070.34
Upgrade
Other Non Operating Income (Expenses)
-16.460.03-1.090.050-0.48
Upgrade
EBT Excluding Unusual Items
-575.28-464.79-332.13-239.48-185.65-86.12
Upgrade
Other Unusual Items
-----0.83-0.88
Upgrade
Pretax Income
-575.28-464.79-332.13-239.48-186.48-87.01
Upgrade
Income Tax Expense
-0.51-1.13-4.06---
Upgrade
Net Income
-574.78-463.66-328.07-239.48-186.48-87.01
Upgrade
Net Income to Common
-574.78-463.66-328.07-239.48-186.48-87.01
Upgrade
Shares Outstanding (Basic)
31627420817612522
Upgrade
Shares Outstanding (Diluted)
31627420817612522
Upgrade
Shares Change (YoY)
44.27%31.92%18.41%40.04%475.48%0.98%
Upgrade
EPS (Basic)
-1.82-1.69-1.58-1.36-1.49-3.99
Upgrade
EPS (Diluted)
-1.82-1.69-1.58-1.36-1.49-3.99
Upgrade
Free Cash Flow
-397.71-372.87-299.74-120.58-198.41-51.23
Upgrade
Free Cash Flow Per Share
-1.26-1.36-1.44-0.69-1.58-2.35
Upgrade
Operating Margin
-960.08%-814.09%-785.33%-616.74%-1795.79%-2135.66%
Upgrade
Profit Margin
-961.32%-788.02%-735.99%-601.05%-1832.18%-2196.01%
Upgrade
Free Cash Flow Margin
-665.17%-633.71%-672.43%-302.64%-1949.42%-1293.03%
Upgrade
EBITDA
-525.58-442.51-325.66-233.97-174.37-80.67
Upgrade
D&A For EBITDA
48.4536.4924.411.768.413.94
Upgrade
EBIT
-574.03-479-350.06-245.73-182.78-84.62
Upgrade
Revenue as Reported
59.7958.8444.5839.8410.183.96
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q